News | October 17, 2007

Radi Focuses on HD Femoral Compression System

October 18, 2007 - At TCT 2007, Radi Medical Systems Inc. focuses on the Femostop HD Femoral Compression System, that with the addition of a hemostatic dressing, promotes dual-action hemostasis, reportedly reducing the need for stocking multiple hemostasis products.
The Femostop Plus Femoral Compression System has been on the market for over 10 years and has been used on over 5 million patients worldwide, according to manufacturer. Incorporating a hemostatic dressing with the Femostop Plus means that both deep and topical hemostasis can be achieved in one, easy to use, clinically validated and widely accepted product.
The hemostatic dressing and Femoral Compression System work together to promote dual-action hemostasis. The hemostatic dressing achieves topical hemostasis that facilitates clotting at the skin incision, while the Femostop provides external compression to facilitate clotting of the arterial puncture wound, thereby achieving deep hemostasis.
According to Radi Medical Systems Inc., recent clinical studies demonstrate the effectiveness of Femostop for 90 minute rapid ambulation. With the incorporation of the hemostatic dressing, safe and rapid hemostasis is now even more convenient for cath lab staff and comfortable for patients.

For more information:

Related Content

Teleflex Acquires Hemostatic Products Vendor Z-Medica
News | Hemostasis Management | February 08, 2021
February 8, 2021 — Teleflex Inc.
Merit Medical Launches PreludeSync Evo Radial Compression Device
News | Hemostasis Management | August 29, 2019
Merit Medical Systems Inc. announced the U.S. commercial launch of the PreludeSync Evo radial compression device. The...
PreludeSync Distal Compression Device Available Globally
Technology | Hemostasis Management | February 01, 2019
Merit Medical Systems Inc. announced that the PreludeSync Distal Compression Device is now available in the United...
nanoparticles, blood clotting, internal bleeding, American Chemical Society study, Erin B. Lavik

Nanoparticles (green) help form clots in an injured liver. The researchers added color to the scanning electron microscopy image after it was taken. Image courtesy of Erin Lavik, Ph.D.

News | Hemostasis Management | August 24, 2016
August 24, 2016 — Whether severe trauma occurs on the battlefield or the highway, saving lives often comes down to...
News | Hemostasis Management | January 06, 2016
The Medicines Company announced Dec. 18 it has entered into a purchase agreement pursuant to which certain subsidiaries...